ArticlePreventing chronic disease2023
Up-to-Date Breast, Cervical, and Colorectal Cancer Screening Test Use in the United States, 2021.
Article in Preventing chronic disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
63 citing papers in PubMed.
- Race, ethnicity, and prior colorectal screening test use in CONFIRM colonoscopy vs fecal immunochemical testing trial participants.JNCI cancer spectrum · 2026Trial
- From SMS Text Messaging to Screening Completion: Understanding How SMS Responses Influence Cancer Screening Uptake in Federally Qualified Health Center Clinics.Health services research · 2026Trial
- Behaviorally Informed Text Messaging to Promote Colon Cancer Screening: A Quality Improvement Randomized Clinical Trial.JAMA network open · 2026Trial
- Promoting cervical cancer screening via a mailed HPV self-collection kit: Reactions from screeners and non-screeners.Patient education and counseling · 2026Trial
- Comparative Analysis of Breast and Cervical Screening Adaptability at a Federally Qualified Health Center.Cancer prevention research (Philadelphia, Pa.) · 2026Article
- Racial and/or Ethnic Differences in Adherence to Preventive Care Guidelines among US Adults Using a Nationally Representative Survey of All Eight Major Racial and/or Ethnic Populations.Journal of racial and ethnic health disparities · 2026Article
- Distribution of Gastrointestinal and Dietary Risk Factors Among U.S. Adults Classified as Having Iron Deficiency Anemia Across Diagnostic Thresholds.American journal of hematology · 2026Article
- SNAP Participation and Cancer Screening for Adults With Food Insecurity.JAMA network open · 2026Article
- EBM BLS: Fecal Immunochemical Testing Program was Non-inferior Compared to Colonoscopy Screening for Colorectal Cancer-related Mortality.Journal of general internal medicine · 2026Article
- Update of incidence and survival in patients with cervical cancer in the United States from 2000 to 2021.Journal of gynecologic oncology · 2026Article
- Breast, Cervical, and Colorectal Cancer Screening Rates in Women Aged 45 to 64 Years.JAMA network open · 2026Article
- Capturing Latino Health Disparities: Lessons from Mail- and Community-Based Population Health Surveys in California.Cancer research communications · 2026Article
- Discrete-Event Simulation Modeling Framework for Cancer Interventions and Population Health in R (DESCIPHR): An Open-Source Pipeline.PharmacoEconomics · 2026Article
- Unmet social needs and colorectal cancer testing at 45-49 since the 2021 USPSTF recommendation.Journal of the National Cancer Institute · 2026Article
- Up-to-date prevalence at recommended ages for discontinuing routine colorectal, cervical and lung cancer screening.Journal of the National Cancer Institute · 2026Article
- Feasibility of Using College Students to Increase Cancer Screening Behaviors Among Their Parents.International journal of environmental research and public health · 2026Article
- Improving Colorectal Cancer Screening and Risk Assessment through Predictive Modeling on Medical Images and Records.The American journal of pathology · 2026Article
- Outcomes and cost of patient navigation in increasing colorectal cancer screening in a safety net hospital-based health center.Cancer causes & control : CCC · 2026Article
- Development of an HPV 16 rapid test founded in user-centered design with primary care clinicians.Analytical methods : advancing methods and applications · 2026Article
- Article
3 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionWe examined national estimates of breast, cervical, and colorectal cancer (CRC) screening test use and compared them with Healthy People 2030 national targets. Test use in 2021 was compared with prepandemic estimates.
methodsIn 2022, we used 2021 National Health Interview Survey (NHIS) data to estimate proportions of adults up to date with US Preventive Services Task Force recommendations for breast (women aged 50-74 y), cervical (women aged 21-65 y), and CRC screening (adults aged 50-75 y) across sociodemographic and health care access variables. We compared age-standardized estimates from the 2021 and 2019 NHIS.
resultsPercentages of adults up to date in 2021 were 75.7% (95% CI, 74.4%-76.9%), 75.2% (95% CI, 73.9%-76.4%), and 72.2% (95% CI, 71.2%-73.2%) for breast, cervical, and CRC screening, respectively. Estimates were below 50% among those without a wellness check in 3 years (all screening types), among those without a usual source of care or insurance (aged <65 y) (breast and CRC screening), and among those residing in the US for less than 10 years (CRC screening). Percentages of adults who were up to date with breast and cervical cancer screening and colonoscopy were similar in 2019 and 2021. Fecal occult blood/fecal immunochemical test (FOBT/FIT) use was modestly higher in 2021 (P < .001).
conclusionsIn 2021, approximately 1 in 4 adults of screening age were not up to date with breast, cervical, and CRC screening recommendations, and Healthy People 2030 national targets were not met. Disparities existed across several characteristics, particularly those related to health care access. Breast, cervical, and colonoscopy test use within recommended screening intervals approximated prepandemic levels. FOBT/FIT estimates were modestly higher in 2021.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.